Roche Holding AG - Preferred Stock and Other Adjustments
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The indicator "Preferred-Stock-and-Other-Adjustments" stands at -3.70 Billion Swiss Francs as of 06/30/2025, the lowest value at least since 06/30/2017, the period currently displayed. Regarding the Three-Year-Change of the series, the current value constitutes a decrease of -11.03 percent compared to the value three years prior.
The 3 year change in percent is -11.03.
The 5 year change in percent is -10.18.
The Serie's change in Swiss Francs from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0 Billion.
The Serie's change in Swiss Francs from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -11.03 Billion.
Preferred Stock and Other Adjustments for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Preferred Stock and Other Adjustments | 905,699,262,464.00 |
 | Johnson & Johnson - Preferred Stock and Other Adjustments | 486,508,953,600.00 |
 | AbbVie Inc - Preferred Stock and Other Adjustments | 399,570,305,024.00 |
 | AstraZeneca PLC - Preferred Stock and Other Adjustments | 280,205,508,085.11 |
 | Novartis AG - Preferred Stock and Other Adjustments | 255,096,620,580.91 |